Dr. Margarida Teles Grilo Ruivo (Montpellier / FR), Katherine Olivia Yanes (Irvine, CA / US), Todd Lenz (Riverside, CA / US), Stephanie Matsuno (Irvine, CA / US), Arnault Graindorge (Montpellier / FR), Dr. Maguy Hamie (Beirut / LB), Laurence Berry-Sterkers (Montpellier / FR), Professor Mathieu Gissot (Lille / FR), Dr. Hiba El Hajj (Beirut / LB), Karine G. Le Roch (Riverside, CA / US), Melissa B. Lodoen (Irvine, CA / US), Dr. Maryse Lebrun (Montpellier / FR), Dr. Diana Penarete Vargas (Montpellier / FR)
Programmed-cell death is an antimicrobial mechanism of defense that promotes rapid clearance of intracellular pathogens. Toxoplasma counteracts host immune defenses by secreting effector proteins into host cells; however, how the parasite evades inflammatory cell death and the effectors involved remain poorly characterized. We identified a new Toxoplasma virulence factor that ensures parasite survival by blocking host cell death. RNA-Seq analysis revealed that this rhoptry protein acts as a repressor of host pro-inflammatory responses. THP1 human monocytes infected with a mutant Toxoplasma strain, showed increased nuclear translocation of NF-kB p65, IL-1β and LDH release, compared to infection with wild type or complemented parasites. Moreover, mutant parasites were dramatically impaired in virulence in mice also preventing NF-κB signalling and lytic cell death in BMDM. These findings unravel the role of a major virulence factor of Toxoplasma, supressing inflammatory cell death as a strategy to evade parasite clearance.
We use cookies on our website. Cookies are small (text) files that are created and stored on your device (e.g., smartphone, notebook, tablet, PC). Some of these cookies are technically necessary to operate the website, other cookies are used to extend the functionality of the website or for marketing purposes. Apart from the technically necessary cookies, you are free to allow or not allow cookies when visiting our website.